Vi-CRM197 vaccine
H01_05TP
Phase 2 mab completed
Quick answer
Vi-CRM197 vaccine for Typhoid Fever is a Phase 2 program (mab) at Novartis Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Novartis Pharmaceuticals
- Indication
- Typhoid Fever
- Phase
- Phase 2
- Modality
- mab
- Status
- completed